BriaCell Therapeutics Corp. (BCT.TO)

CAD 5.92

(-1.33%)

Revenue Summary of BriaCell Therapeutics Corp.

  • BriaCell Therapeutics Corp.'s latest annual revenue in 2023 was - USD , down 0.0% from previous year.
  • BriaCell Therapeutics Corp.'s latest quarterly revenue in 2024 Q3 was - USD , down 0.0% from previous quarter.
  • BriaCell Therapeutics Corp. reported a annual revenue of - USD in annual revenue 2022, down 0.0% from previous year.
  • BriaCell Therapeutics Corp. reported a annual revenue of - USD in annual revenue 2021, down 0.0% from previous year.
  • BriaCell Therapeutics Corp. reported a quarterly revenue of - USD for 2024 Q1, down 0.0% from previous quarter.
  • BriaCell Therapeutics Corp. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of BriaCell Therapeutics Corp. (2023 - 2006)

Historical Annual Revenue of BriaCell Therapeutics Corp. (2023 - 2006)

Year Revenue Revenue Growth
2023 - USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%

Peer Revenue Comparison of BriaCell Therapeutics Corp.

Name Revenue Revenue Difference
Appili Therapeutics Inc. 827.4 Thousand CAD 100.0%
Eupraxia Pharmaceuticals Inc. - CAD NaN%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 16.51 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Satellos Bioscience Inc. - CAD NaN%
Oncolytics Biotech Inc. - CAD NaN%
Sernova Corp. - CAD NaN%